Inactive Instrument

RISE Life Science Corp.

RLSC

CA76761F1053

RISE Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021

July 29, 2021

RISE Life Science Corp. announced earnings results for the second quarter ended May 31, 2021. For the second quarter, the company announced net income was CAD 4.884 million compared to net loss of CAD 639,673 a year ago. For the half year, net income was CAD 4.865 million compared to net loss of CAD 1.287 million a year ago.

Latest news about RISE Life Science Corp.

Britannia Bud Canada Holdings Inc. completed the acquisition of RISE Life Science Corp. in a reverse merger transaction.	21-11-11	CI
RISE Life Science Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021	21-11-01	CI
Scientus Pharma Inc. cancelled the acquisition of RISE Life Science Corp. in a reverse merger transaction.	21-10-29	CI
RISE Life Science Corp. Appoints Greg Taylor as Board of Director	21-09-01	CI
RISE Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021	21-07-29	CI
Rise Life Science Corp. Reports Earnings Results for the First Quarter Ended February 28, 2021	21-04-28	CI
RISE Life Science Corp. announced that it has received $1.331 million in funding	21-04-14	CI
Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2020	21-03-29	CI
RISE Life Science Corp. announced that it expects to receive $0.71 million in funding	21-03-03	CI
Britannia Bud Canada Holdings Inc. entered into a Letter of intent to acquire RISE Life Science Corp. in a reverse merger transaction.	21-01-21	CI
Rise Life Science Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2020	20-10-30	CI
Rise Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2020	20-07-28	CI
RISE Life Science Corp. announced that it expects to receive CAD 10 million in funding	20-04-12	CI
Scientus Pharma Inc. entered into a binding letter agreement to acquire RISE Life Science Corp. for CAD 0.3 million in a reverse merger transaction.	20-04-12	CI
Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2019	20-04-05	CI
Rise Life Science Corp. Announces Michael Campbell Has Stepped Down as Director	19-12-24	CI
Rise Life Science Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2019	19-10-29	CI
RISE Life Science Corp. Announces Resignation of Ryan Rocca as Director	19-08-19	CI
Rise Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2019	19-07-30	CI
RISE Life Science Corp. Launches Retail Location on Main Street in Santa Monica, California	19-06-14	CI
RISE Life Science Corp. Announces Management Changes	19-04-30	CI
RISE Life Science Corp. Provides Operational Update	19-04-30	CI
Rise Life Science Corp. Reports Earnings Results for the First Quarter Ended February 28, 2019	19-04-29	CI
RISE Life Science Corp. Announces Hemp-Based CBD Product Approval for Distribution in Mexico	19-04-17	CI
RISE Life Science Corp. Announces Two New Oral Spray Formulas to Its Suite of Product Offerings	19-04-16	CI

Chart RISE Life Science Corp.

Duration

Period

More charts

Company Profile

Britannia Life Sciences Inc, formerly RISE Life Science Corp, is a Canada-based vertically diversified product development company. The Company's platform provides an integrated, one-stop shop service for product development, testing, safety & compliance and consumer evaluations/trials. Its principal activities include quality ingredients, formulations, safety assessment, analytical & quality assessments, global compliance and regulation, consumer trials and evaluations for various sectors. It serves Consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

Sector

Food Processing

More about the company

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG NHU COMPANY LTD.	+11.32%	7.78B
BELLRING BRANDS, INC.	+1.64%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.50%	6.52B
BYHEALTH CO., LTD	-6.69%	3.67B
THE SIMPLY GOOD FOODS COMPANY	-13.51%	3.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-10.10%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-41.81%	879M
USANA HEALTH SCIENCES, INC.	-19.81%	836M

Special Foods & Wellbeing Products